The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT04699123 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04699123
- Sponsor
- Yale University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2026-12-30
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.